Summary of Guidelines for the Treatment of Lumbar Spondylolisthesis

Andrew K Chan; Viraj Sharma; Leslie C Robinson; Praveen V Mummaneni

doi:10.1016/j.nec.2019.02.009

Summary of Guidelines for the Treatment of Lumbar Spondylolisthesis

Neurosurg Clin N Am. 2019 Jul;30(3):353-364. doi: 10.1016/j.nec.2019.02.009.

Authors

Andrew K Chan¹, Viraj Sharma², Leslie C Robinson², Praveen V Mummaneni²

Affiliations

¹ Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue M779, San Francisco, CA 94143, USA. Electronic address: andrew.chan@ucsf.edu.
² Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue M779, San Francisco, CA 94143, USA.

PMID: 31078236
DOI: 10.1016/j.nec.2019.02.009

Abstract

Degenerative lumbar spondylolisthesis is a common cause of low back pain, affecting about 11.5% of the United States population. Patients with symptomatic lumbar spondylolisthesis may first be treated with conservative management strategies including, but not limited to, non-narcotic and narcotic pain medications, epidural steroid injections, transforaminal injections, and physical therapy. For well-selected patients who fail conservative management strategies, surgical management is appropriate. This article summarizes the guidelines for the treatment of lumbar spondylolisthesis.

Keywords: Clinical guidelines; Degenerative lumbar spondylolisthesis; Interbody; Minimally invasive surgery; Spinal decompression; Spinal fusion; Spinal laminectomy.

Publication types

Review

MeSH terms

Humans
Low Back Pain / surgery*
Lumbar Vertebrae / surgery
Lumbosacral Region / surgery*
Pain Measurement*
Spondylolisthesis / diagnostic imaging
Spondylolisthesis / surgery*
Treatment Outcome